Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Author:

Modi Shanu1,Jacot William1,Yamashita Toshinari1,Sohn Joohyuk1ORCID,Vidal Maria1,Tokunaga Eriko1,Tsurutani Junji1,Ueno Naoto T.1,Prat Aleix1,Chae Yee Soo1,Lee Keun Seok1,Niikura Naoki1,Park Yeon Hee1,Xu Binghe1,Wang Xiaojia1,Gil-Gil Miguel1,Li Wei1,Pierga Jean-Yves1,Im Seock-Ah1,Moore Halle C.F.1,Rugo Hope S.1,Yerushalmi Rinat1,Zagouri Flora1,Gombos Andrea1,Kim Sung-Bae1,Liu Qiang1,Luo Ting1,Saura Cristina1,Schmid Peter1,Sun Tao1,Gambhire Dhiraj1,Yung Lotus1,Wang Yibin1,Singh Jasmeet1,Vitazka Patrik1,Meinhardt Gerold1,Harbeck Nadia1,Cameron David A.1

Affiliation:

1. From the Memorial Sloan Kettering Cancer Center, New York (S.M.); Institut du Cancer de Montpellier, Université Montpellier, INSERM Unité 1194, Montpellier (W.J.), and Institut Curie, Université Paris Cité, Paris (J.-Y.P.) — both in France; Kanagawa Cancer Center, Yokohama (T.Y.), Kyushu Cancer Center, National Hospital Organization, Fukuoka (E.T.), Showa University Hospital, Tokyo (J.T.), and Tokai University School of Medicine, Isehara-shi (N.N.) — all in Japan; Yonsei Cancer Center, Yonsei University...

Funder

Daiichi Sankyo

AstraZeneca

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3